Third Quarter and Recent Business Highlights: KALA’s innovative pipeline is based on its proprietary mesenchymal stem cell secretome (MSC-S) platform. KALA believes the multifactorial mechanism of ...
Clinicians will soon gain access to trusted education on stem cell-based therapies through a new Continuing Education (CE) course developed by the International Society of Stem Cell Research (ISSCR).